LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 28 of 497
Next
>>
>
676 to 700 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	WZ3105	0.12	uM	LJP5	1	D23	72	hr	1657	2308	5505	0.4192	0.1690
BT-20	WZ3105	0.12	uM	LJP5	2	D23	72	hr	1657	2077	5505	0.3773	0.1090
BT-20	WZ3105	0.12	uM	LJP5	3	D23	72	hr	1657	2224	5505	0.4040	0.1472
BT-20	XMD11-50	0.12	uM	LJP6	1	P11	72	hr	1657	5030	5505	0.9136	0.8764
BT-20	XMD11-50	0.12	uM	LJP6	2	P11	72	hr	1657	4746	5505	0.8620	0.8026
BT-20	XMD11-50	0.12	uM	LJP6	3	P11	72	hr	1657	4831	5505	0.8775	0.8247
BT-20	Y39983	0.12	uM	LJP6	1	P05	72	hr	1657	5397	5505	0.9803	0.9718
BT-20	Y39983	0.12	uM	LJP6	2	P05	72	hr	1657	5448	5505	0.9895	0.9850
BT-20	Y39983	0.12	uM	LJP6	3	P05	72	hr	1657	5177	5505	0.9403	0.9146
BT-20	YM 201636	0.12	uM	LJP5	1	N11	72	hr	1657	5409	5505	0.9824	0.9749
BT-20	YM 201636	0.12	uM	LJP5	2	N11	72	hr	1657	5642	5505	1.0248	1.0354
BT-20	YM 201636	0.12	uM	LJP5	3	N11	72	hr	1657	5289	5505	0.9607	0.9437
BT-20	ZSTK474	0.12	uM	LJP6	1	M17	72	hr	1657	4973	5505	0.9033	0.8616
BT-20	ZSTK474	0.12	uM	LJP6	2	M17	72	hr	1657	4928	5505	0.8951	0.8499
BT-20	ZSTK474	0.12	uM	LJP6	3	M17	72	hr	1657	4786	5505	0.8693	0.8130
BT-20	Afatinib	0.37	uM	LJP6	1	G22	72	hr	1657	4262	5505	0.7741	0.6768
BT-20	Afatinib	0.37	uM	LJP6	2	G22	72	hr	1657	5137	5505	0.9330	0.9042
BT-20	Afatinib	0.37	uM	LJP6	3	G22	72	hr	1657	4673	5505	0.8488	0.7836
BT-20	Sigma A6730	0.37	uM	LJP5	1	B22	72	hr	1657	5286	5505	0.9601	0.9429
BT-20	Sigma A6730	0.37	uM	LJP5	2	B22	72	hr	1657	5153	5505	0.9359	0.9084
BT-20	Sigma A6730	0.37	uM	LJP5	3	B22	72	hr	1657	5125	5505	0.9309	0.9011
BT-20	Alvocidib	0.37	uM	LJP6	1	A16	72	hr	1657	1177	5505	0.2138	-0.1249
BT-20	Alvocidib	0.37	uM	LJP6	2	A16	72	hr	1657	1209	5505	0.2196	-0.1166
BT-20	Alvocidib	0.37	uM	LJP6	3	A16	72	hr	1657	1348	5505	0.2448	-0.0805
BT-20	AT-7519	0.37	uM	LJP6	1	K04	72	hr	1657	1815	5505	0.3297	0.0409

|<
<<
Previous
Page 28 of 497
Next
>>
>
676 to 700 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)